Clik here to view.
Solasia从Camurus获得episil®口服液在日本和中国的独家授权和分销权
瑞典隆德和东京 (美国商业资讯)–Camurus AB (“Camurus”)和Solasia Pharma K.K. (“Solasia”)今天联合宣布，两家公司已签署一项有关episil®口服液的授权和分销协议，该口服液是一种有效治疗口腔粘膜炎和其他口腔病灶的独特药物，口腔粘膜炎是部分抗癌疗法的一种治疗限制性副作用。...
View ArticleClik here to view.
Berry Genomics NextSeq CN500 Instrument and Non-Invasive Prenatal Testing...
BEIJING & SAN DIEGO Berry Genomics Co., Ltd. announced today that Hangzhou Berry Genomics, a subsidiary of Berry Genomics Co., Ltd., has received premarket clearance from the Chinese Food and...
View ArticleClik here to view.
Acucela Granted New Patent Covering Method of Use for Emixustat Hydrochloride
SEATTLE Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of...
View ArticleClik here to view.
Macrogen Renews CI after 19 Years, Making a Great Leap Forward to Be a Global...
SEOUL, South Korea The personalized medicine and biotechnology company, Macrogen (headed by Hyonyong Chong; www.macrogen.com) (KOSDAQ:038290), has announced a new Corporate Identity (CI) for a great...
View ArticleClik here to view.
Provision Healthcare and Tianjin Taishan Cancer Hospital Partner to Develop...
KNOXVILLE, Tenn. Provision Healthcare has signed a joint agreement with the Tianjin Taishan Cancer Hospital (International Personalized Cancer Center, “IPCC”) in northern China to build the first...
View ArticleClik here to view.
International Forum on Consciousness: Conscious Evolution: The Awakening
MADISON, Wis. Conscious Evolution: The Awakening is the theme for this year’s International Forum on Consciousness, to be held May 7-8 in Fitchburg/Madison, Wisconsin. Hosted by the...
View ArticleClik here to view.
エリテックが2014年通期のビジネスアップデートと決算を報告
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（ADR:EYRYY）（Euronext Paris: ERYP & OTC US:...
View ArticleClik here to view.
Clik here to view.
WaVe Life Sciences Appoints Roberto Guerciolini, M.D., as Senior Vice...
BOSTON & OKINAWA, Japan WaVe Life Sciences today announced that Roberto Guerciolini, M.D., has been appointed as Senior Vice President and Head of Early Development. He was most recently Vice...
View ArticleClik here to view.
Promega Nano-Glo® Dual-Luciferase® Reporter Assay Enables More Sensitive...
MADISON, Wis. Promega Corporation announces the launch of the new Nano-Glo® Dual-Luciferase® Reporter (NanoDLR™) Assay, a two-reporter system that incorporates NanoLuc® luciferase technology,...
View ArticleClik here to view.
Provectus Biopharmaceuticals to Present at 7th Annual International...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”),...
View ArticleClik here to view.
IBA and Toshiba Sign Strategic Partnership in Particle Therapy
LOUVAIN-LA-NEUVE, Belgium & TOKYO IBA (Ion Beam Applications S.A.) and Toshiba Corporation (TOKYO:6502) today announce the signing of a global collaboration to expand access to advanced particle...
View ArticleClik here to view.
IBA与东芝签署粒子疗法战略伙伴关系
比利时LOUVAIN-LA-NEUVE和东京 (美国商业资讯) — IBA (Ion Beam Applications S.A.)与东芝公司(TOKYO:6502)今天宣布签署一份全球合作协议，以拓展世界各地的先进粒子疗法可及性。东芝医疗系统公司(Toshiba Medical Systems...
View ArticleClik here to view.
Mach7 Technologies Partners with Broward Health
BURLINGTON, Vt. & CHICAGO Broward Health, one of the largest IDNs in the U.S., selected Mach7 Technologies® and their award-winning Mach7 Enterprise Imaging Platform to deploy enterprise-wide in...
View ArticleClik here to view.
Novacyt Raises €2.2M to Accelerate NOVAprep Launch in China and Announces...
PARIS & CAMBRIDGE, England Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces a private equity placement financing of €2.2m....
View ArticleClik here to view.
WINコンソーシアムが転移性肺がんにおける生存期間を大きく延ばすべく、3剤併用標的化療法戦略を統括する特別顧問にワン・キ・ホン教授を任命
パリ （ビジネスワイヤ）– ワールドワイド・イノベーティブ・ネットワーク –...
View ArticleClik here to view.
WIN联盟任命Waun Ki Hong教授为特别顾问，掌管其三药联合靶向疗法策略，以大幅提高转移性肺癌患者的生存率
巴黎 (美国商业资讯)–全球创新网络 – WIN 联盟今天宣布，任命德州大学MD Anderson癌症中心教授Waun Ki Hong为执行委员会特别顾问和委员。Waun Ki Hong 教授将掌管WIN联盟的新策略及下一代临床试验，这些临床试验旨在大幅提高肺癌患者的总生存率。这些计划将于6月29-30日在法国巴黎召开的WIN 2015 年度研讨会上披露。 Prof. Waun Ki Hong...
View ArticleClik here to view.
pSivida Corp. Reports ILUVIEN® for DME Approved in Poland
WATERTOWN, Mass. pSivida Corp. (NASDAQ:PSDV; ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that the Office for...
View ArticleClik here to view.
IncellDxが新規のリキッドバイオプシー技術を商業化すべくクレアモント・バイオソリューションズと独占ライセンス契約を締結
米カリフォルニア州メンロパーク （ビジネスワイヤ） — IncellDx,...
View ArticleClik here to view.
IncellDx, Inc.与Claremont BioSolutions签署新型液相活检技术商业化的独家授权
加州门洛帕克 (美国商业资讯)–IncellDx, Inc.今天宣布与Claremont...
View Article